Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Personal website of qntm.THERE IS NO ANTIMEMETICS DIVISIONThe legendary, brain-melting sci-fi thriller. OUT NOW. (Also award-nominated!) Today in Things Of Interest...
News
Investornewsbreaks Quantum Biopharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy To Phase 2 Development
Read more
Report
We had a unit test once which only failed on Sundays
Non-deterministic datetime parsing combined with a failure to mock the current time.We were parsing the string "00-54" with the date format "YY-ww", where the "ww" indicates "ISO 8601 week number with leading zero", then serialising the resulting date obj
Read more
Report
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Advances Myelin-Protecting MS Therapy as Treatment Paradigm Evolves
Detailed price information for Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM-CN) from The Globe and Mail including charting and trades.
Read more
Report
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis
Detailed price information for Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM-CN) from The Globe and Mail including charting and trades.
Read more
Report
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2
Austin, Texas, August 10th, 2026, FinanceWireThis article has been disseminated on behalf of Quantum BioPharma Ltd. ...
Read more
Report
Pro access
Upgrade to see all 39 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
